KX2-391 Ointment 1%

· Almirall, S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KX2-391 Ointment 1%, covering 2021-03-10 to 2021-03-10. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp [Phase 3]